Navigation Links
Faulty Dosing Device Prompts Recall of Infants' Tylenol
Date:2/17/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 17 (HealthDay News) -- A potentially faulty dosing system on bottles of Infants' Tylenol has prompted McNeil Consumer Healthcare, a division of Johnson & Johnson, to recall all of the product.

The voluntary recall comes in response to some consumer complaints about the product's so-called SimpleMeasure dosing system, which dispenses measured doses of the medication.

The system includes a dosing syringe that an adult inserts into the cover at the top of the bottle. It's supposed to limit the amount of Tylenol that can be delivered in a single dose, according to the company.

In some cases, inserting the syringe pushed this "flow restrictor" into the bottle.

"Parents can continue to use the product as long as the flow restrictor is in place," Johnson & Johnson spokeswoman Bonnie Jacobs said. "If the flow restrictor does push into the bottle, then they should stop using it and contact us."

According to the company, there have been no adverse events reported due to the problem, "and the risk of a serious adverse medical event is remote."

Jacobs said she didn't know when Infants' Tylenol would be available again. "We're conducting a full review to determine why it's not performing as expected. We are looking at different options," she said.

The recall affects only Infants' Tylenol. Children's Tylenol, which is for use by children 2 years of age and older, remains on the market, Jacobs said.

More information

For more information, visit Johnson & Johnson.

SOURCE: Bonnie Jacobs, spokeswoman, Johnson & Johnson


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Journal Retracts Faulty Chronic Fatigue Study
2. Autism Tests for Preemies May Be Faulty, Study Suggests
3. Faulty off-switch stops children with ADHD from concentrating
4. Drug Targets Faulty Process That Drives Cystic Fibrosis
5. Web Site for Hospital Comparisons Is Faulty: Study
6. Faulty gene stops cell antennae from transmitting
7. Variation in make-up of generic epilepsy drugs can lead to dosing problems
8. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
9. Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
10. Confusion Over Drug Dosing Common for Seniors
11. Cough Syrup Might Help With Dosing of Breast Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Faulty Dosing Device Prompts Recall of Infants' Tylenol
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: